• Home
  • Search Results

Search Results

2553 studies match your search
Open

Endometrial Cancer Study

Do you have grade 1 or 2 edometrioid endometrial cancer? You may be able to take part in a study to learn more about and test a new drug.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
  • Women's Health
Not currently enrolling

Alogabat

This trial will be testing a new drug called Alogabat that is meant to help 5-17 year olds with Angelman Syndrome.

Age & Gender
  • 5 years ~ 17 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Developmental
  • Parents of Children
  • and 3 more
Open

Study of Triple Negative Breast Cancer with Residual Invasive Disease

Have you been diagnosed with high-risk early triple-negative breast cancer (TNBC) without mutations in the BRCA1 or BRCA2 gene? If you still have evidence of TNBC in your breast or lymph node tissue after receiving treatment and surgery, you may qualify for this clinical research study. This study will test an experimental drug combination to find out which treatment is better at delaying the return of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Visit Location
Open

Changes in metabolic hormones and eating behaviors before and after weight loss surgery

Are you scheduled for weight loss surgery within the next 12 months? You may be able to take part in a research study to help us learn more about your metabolic hormones, eating behaviors, stress, and weight loss before and after your surgery.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Mental and Emotional Health
  • Wellness and Lifestyle
  • and 3 more
Not currently enrolling

Gender and Autism Project

The goal of this study is to create a support group and resources for adolescents who identify as both autistic and gender diverse using input from adolescents, parents, and professionals.

Age & Gender
  • 10 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • LGBTQIA+
  • Mental and Emotional Health
  • Parents of Children
Visit Location
100% Remote (online, phone, text)
Open

Drug that may help Cutaneous Lupus Erythematosus

Do you have Cutaneous Lupus Erythematosus (CLE)? If you have tried antimalarials but they haven't helped your skin get better, you may be able to take part in a research study. In this study, we want to find out if a new drug improves the skin of patients with CLE. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Chronic Conditions
  • Skin, Hair, and Nails
Not currently enrolling

Sitting Interruption Study

In this study, we want to learn more about two strategies that interrupt sitting: walking and seated pedaling. Sitting, or sedentary behavior, is a public health crisis that increases all causes of mortality and doubles the risk of cardiovascular disease. Interrupting sitting may help reduce the cardiovascular disease risk associated with uninterrupted bouts of sitting.

Age & Gender
  • 45 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Blood Pressure
  • Diabetes
  • and 9 more
Open

Nutrition for Precision Health - Tailored Nutrition Study

Nutrition is not one-size-fits-all. Nutrition, or the foods we eat, can help prevent and fight conditions such as high blood pressure, diabetes, stroke, and more. However, we all live in different environments, we come from different cultures, and each of us is starting from a different place with our health. Additionally, everyone breaks down food differently. Join the Nutrition for Precision Health research study to help researchers learn how our genes, cultural backgrounds, and environments affect our bodies' responses to food. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Open

An Open-label, Multicenter Study of LOXO-435 in Advanced Solid Tumor Malignancies with FGFR3 Alterations

Have you been diagnosed with cancer and either your cancer did not respond to treatment or your cancer progressed? If so, you may be able to take part in a research study evaluating the safety of an investigational treatment called LOXO-435 in cancer patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Other Cancers)
Open

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Do you have endometrial cancer? ]. If so, you may be able to take part in a research study looking at the safety of giving a combination treatment of the drugs ONC201 plus Atezolizumab to patients with endometrial cancer.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research